Advertisement
Advertisement

ACHV

ACHV logo

Achieve Life Sciences, Inc.

5.30
USD
Sponsored
+0.29
+5.79%
Jun 24, 16:00 UTC -4
Closed
exchange

After-Market

5.32

+0.02
+0.28%

ACHV Earnings Reports

Positive Surprise Ratio

ACHV beat 19 of 35 last estimates.

54%

Next Report

Date of Next Report
Aug 05, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/
-$0.16
Implied change from Q1 26 (Revenue/ EPS)
--
/
-15.79%
Implied change from Q2 25 (Revenue/ EPS)
--
/
-56.76%

Achieve Life Sciences, Inc. earnings per share and revenue

On May 12, 2026, ACHV reported earnings of -0.19 USD per share (EPS) for Q1 26, beating the estimate of -0.31 USD, resulting in a 39.59% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +7.16% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 5 analysts forecast an EPS of -0.16 USD, with revenue projected to reach -- USD, implying an decrease of -15.79% EPS, and increase of 0.00% in Revenue from the last quarter.
FAQ
For Q1 2026, Achieve Life Sciences, Inc. reported EPS of -$0.19, beating estimates by 39.59%, and revenue of $0.00, 0% as expectations.
The stock price moved up 7.16%, changed from $5.59 before the earnings release to $5.99 the day after.
The next earning report is scheduled for Aug 05, 2026.
Based on 5 analysts, Achieve Life Sciences, Inc. is expected to report EPS of -$0.16 and revenue of -- for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement